0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Veterinary Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-12116
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Veterinary Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12116
Report
March 2024
Pages:163
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Vaccine - Market Size

The global market for Veterinary Vaccine was estimated to be worth US$ 10810 million in 2023 and is forecast to a readjusted size of US$ 17260 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Veterinary Vaccine - Market

Veterinary Vaccine - Market

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global veterinary vaccine key players include Merck, Zoetis, Boehringer Ingelheim, Ceva, and others. The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%. Global origins are mainly in North America, Europe, China, India, Latin America, South America, South Korea, Japan, Turkey, Middle East, Southeast Asia, etc. In terms of their products, live attenuated vaccines have the largest market share with a 50% share, followed by inactivated vaccines. In terms of its application, farm animals are the number one target, with a 70% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Veterinary Vaccine by region & country, by Type, and by Application.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
Market Segmentation

Scope of Veterinary Vaccine - Market Report

Report Metric Details
Report Name Veterinary Vaccine - Market
Forecasted market size in 2030 US$ 17260 million
CAGR 6.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Other
Segment by Application
  • Farm Animal
  • Companion Animal
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, RVSRI, Medion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Veterinary Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Veterinary Vaccine - Market size in 2030?

Ans: The Veterinary Vaccine - Market size in 2030 will be US$ 17260 million.

What is the market share of major companies in Veterinary Vaccine - Market?

Ans: The top three producers together account for more than 60% of the market share, with Merck being the largest producer with approximately 25%.

Who are the main players in the Veterinary Vaccine - Market report?

Ans: The main players in the Veterinary Vaccine - Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, RVSRI, Medion

What are the Application segmentation covered in the Veterinary Vaccine - Market report?

Ans: The Applications covered in the Veterinary Vaccine - Market report are Farm Animal, Companion Animal

What are the Type segmentation covered in the Veterinary Vaccine - Market report?

Ans: The Types covered in the Veterinary Vaccine - Market report are Live Attenuated Vaccines, Inactivated Vaccines, Other

1 Market Overview
1.1 Veterinary Vaccine Product Introduction
1.2 Global Veterinary Vaccine Market Size Forecast
1.2.1 Global Veterinary Vaccine Sales Value (2019-2030)
1.2.2 Global Veterinary Vaccine Sales Volume (2019-2030)
1.2.3 Global Veterinary Vaccine Sales Price (2019-2030)
1.3 Veterinary Vaccine Market Trends & Drivers
1.3.1 Veterinary Vaccine Industry Trends
1.3.2 Veterinary Vaccine Market Drivers & Opportunity
1.3.3 Veterinary Vaccine Market Challenges
1.3.4 Veterinary Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Vaccine Players Revenue Ranking (2023)
2.2 Global Veterinary Vaccine Revenue by Company (2019-2024)
2.3 Global Veterinary Vaccine Players Sales Volume Ranking (2023)
2.4 Global Veterinary Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Veterinary Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Veterinary Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Veterinary Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine
2.9 Veterinary Vaccine Market Competitive Analysis
2.9.1 Veterinary Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Veterinary Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Attenuated Vaccines
3.1.2 Inactivated Vaccines
3.1.3 Other
3.2 Global Veterinary Vaccine Sales Value by Type
3.2.1 Global Veterinary Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Veterinary Vaccine Sales Volume by Type
3.3.1 Global Veterinary Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Veterinary Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Veterinary Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Veterinary Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Farm Animal
4.1.2 Companion Animal
4.2 Global Veterinary Vaccine Sales Value by Application
4.2.1 Global Veterinary Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Veterinary Vaccine Sales Volume by Application
4.3.1 Global Veterinary Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Veterinary Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Veterinary Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Vaccine Sales Value by Region
5.1.1 Global Veterinary Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Veterinary Vaccine Sales Volume by Region
5.2.1 Global Veterinary Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Veterinary Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Veterinary Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Veterinary Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Veterinary Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Veterinary Vaccine Sales Value, 2019-2030
5.4.2 North America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Veterinary Vaccine Sales Value, 2019-2030
5.5.2 Europe Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Veterinary Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Veterinary Vaccine Sales Value, 2019-2030
5.7.2 South America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Veterinary Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Vaccine Sales Value
6.2.1 Key Countries/Regions Veterinary Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Veterinary Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Veterinary Vaccine Sales Value, 2019-2030
6.3.2 United States Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Vaccine Sales Value, 2019-2030
6.4.2 Europe Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Vaccine Sales Value, 2019-2030
6.5.2 China Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Vaccine Sales Value, 2019-2030
6.6.2 Japan Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Vaccine Sales Value, 2019-2030
6.7.2 South Korea Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Vaccine Sales Value, 2019-2030
6.9.2 India Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Veterinary Vaccine Product Offerings
7.1.5 Merck Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Veterinary Vaccine Product Offerings
7.2.5 Zoetis Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Information
7.3.2 Boehringer Ingelheim Introduction and Business Overview
7.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Veterinary Vaccine Product Offerings
7.3.5 Boehringer Ingelheim Recent Development
7.4 Ceva
7.4.1 Ceva Company Information
7.4.2 Ceva Introduction and Business Overview
7.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Veterinary Vaccine Product Offerings
7.4.5 Ceva Recent Development
7.5 CAHIC
7.5.1 CAHIC Company Information
7.5.2 CAHIC Introduction and Business Overview
7.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CAHIC Veterinary Vaccine Product Offerings
7.5.5 CAHIC Recent Development
7.6 HVRI
7.6.1 HVRI Company Information
7.6.2 HVRI Introduction and Business Overview
7.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 HVRI Veterinary Vaccine Product Offerings
7.6.5 HVRI Recent Development
7.7 Ringpu Biology
7.7.1 Ringpu Biology Company Information
7.7.2 Ringpu Biology Introduction and Business Overview
7.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ringpu Biology Veterinary Vaccine Product Offerings
7.7.5 Ringpu Biology Recent Development
7.8 Yebio
7.8.1 Yebio Company Information
7.8.2 Yebio Introduction and Business Overview
7.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Yebio Veterinary Vaccine Product Offerings
7.8.5 Yebio Recent Development
7.9 DHN
7.9.1 DHN Company Information
7.9.2 DHN Introduction and Business Overview
7.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 DHN Veterinary Vaccine Product Offerings
7.9.5 DHN Recent Development
7.10 WINSUN
7.10.1 WINSUN Company Information
7.10.2 WINSUN Introduction and Business Overview
7.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WINSUN Veterinary Vaccine Product Offerings
7.10.5 WINSUN Recent Development
7.11 Elanco
7.11.1 Elanco Company Information
7.11.2 Elanco Introduction and Business Overview
7.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Elanco Veterinary Vaccine Product Offerings
7.11.5 Elanco Recent Development
7.12 Virbac
7.12.1 Virbac Company Information
7.12.2 Virbac Introduction and Business Overview
7.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Virbac Veterinary Vaccine Product Offerings
7.12.5 Virbac Recent Development
7.13 Jinyu Bio-Technology
7.13.1 Jinyu Bio-Technology Company Information
7.13.2 Jinyu Bio-Technology Introduction and Business Overview
7.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Offerings
7.13.5 Jinyu Bio-Technology Recent Development
7.14 ChengDu Tecbond
7.14.1 ChengDu Tecbond Company Information
7.14.2 ChengDu Tecbond Introduction and Business Overview
7.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ChengDu Tecbond Veterinary Vaccine Product Offerings
7.14.5 ChengDu Tecbond Recent Development
7.15 CAVAC
7.15.1 CAVAC Company Information
7.15.2 CAVAC Introduction and Business Overview
7.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 CAVAC Veterinary Vaccine Product Offerings
7.15.5 CAVAC Recent Development
7.16 Kyoto Biken Laboratories
7.16.1 Kyoto Biken Laboratories Company Information
7.16.2 Kyoto Biken Laboratories Introduction and Business Overview
7.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Offerings
7.16.5 Kyoto Biken Laboratories Recent Development
7.17 FATRO
7.17.1 FATRO Company Information
7.17.2 FATRO Introduction and Business Overview
7.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 FATRO Veterinary Vaccine Product Offerings
7.17.5 FATRO Recent Development
7.18 Vaksindo
7.18.1 Vaksindo Company Information
7.18.2 Vaksindo Introduction and Business Overview
7.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Vaksindo Veterinary Vaccine Product Offerings
7.18.5 Vaksindo Recent Development
7.19 Bio-Labs
7.19.1 Bio-Labs Company Information
7.19.2 Bio-Labs Introduction and Business Overview
7.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Bio-Labs Veterinary Vaccine Product Offerings
7.19.5 Bio-Labs Recent Development
7.20 Avimex Animal Health
7.20.1 Avimex Animal Health Company Information
7.20.2 Avimex Animal Health Introduction and Business Overview
7.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Avimex Animal Health Veterinary Vaccine Product Offerings
7.20.5 Avimex Animal Health Recent Development
7.21 MEVAC
7.21.1 MEVAC Company Information
7.21.2 MEVAC Introduction and Business Overview
7.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.21.4 MEVAC Veterinary Vaccine Product Offerings
7.21.5 MEVAC Recent Development
7.22 Biovac
7.22.1 Biovac Company Information
7.22.2 Biovac Introduction and Business Overview
7.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Biovac Veterinary Vaccine Product Offerings
7.22.5 Biovac Recent Development
7.23 Atafen
7.23.1 Atafen Company Information
7.23.2 Atafen Introduction and Business Overview
7.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Atafen Veterinary Vaccine Product Offerings
7.23.5 Atafen Recent Development
7.24 Dyntec
7.24.1 Dyntec Company Information
7.24.2 Dyntec Introduction and Business Overview
7.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Dyntec Veterinary Vaccine Product Offerings
7.24.5 Dyntec Recent Development
7.25 RVSRI
7.25.1 RVSRI Company Information
7.25.2 RVSRI Introduction and Business Overview
7.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.25.4 RVSRI Veterinary Vaccine Product Offerings
7.25.5 RVSRI Recent Development
7.26 Medion
7.26.1 Medion Company Information
7.26.2 Medion Introduction and Business Overview
7.26.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.26.4 Medion Veterinary Vaccine Product Offerings
7.26.5 Medion Recent Development
8 Industry Chain Analysis
8.1 Veterinary Vaccine Industrial Chain
8.2 Veterinary Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Veterinary Vaccine Market Trends
    Table 2. Veterinary Vaccine Market Drivers & Opportunity
    Table 3. Veterinary Vaccine Market Challenges
    Table 4. Veterinary Vaccine Market Restraints
    Table 5. Global Veterinary Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Veterinary Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Veterinary Vaccine Sales Volume by Company (2019-2024) & (M Doses)
    Table 8. Global Veterinary Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Veterinary Vaccine Price by Company (2019-2024) & (USD/K Doses)
    Table 10. Key Manufacturers Veterinary Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Veterinary Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Veterinary Vaccine
    Table 13. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Veterinary Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Veterinary Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Veterinary Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Veterinary Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Veterinary Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Veterinary Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)
    Table 22. Global Veterinary Vaccine Sales Volume by Type (2019-2024) & (M Doses)
    Table 23. Global Veterinary Vaccine Sales Volume by Type (2025-2030) & (M Doses)
    Table 24. Global Veterinary Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Veterinary Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Veterinary Vaccine Price by Type (2019-2024) & (USD/K Doses)
    Table 27. Global Veterinary Vaccine Price by Type (2025-2030) & (USD/K Doses)
    Table 28. Global Veterinary Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Veterinary Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Veterinary Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Veterinary Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Veterinary Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Veterinary Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)
    Table 34. Global Veterinary Vaccine Sales Volume by Application (2019-2024) & (M Doses)
    Table 35. Global Veterinary Vaccine Sales Volume by Application (2025-2030) & (M Doses)
    Table 36. Global Veterinary Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Veterinary Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Veterinary Vaccine Price by Application (2019-2024) & (USD/K Doses)
    Table 39. Global Veterinary Vaccine Price by Application (2025-2030) & (USD/K Doses)
    Table 40. Global Veterinary Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Veterinary Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Veterinary Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Veterinary Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Veterinary Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Veterinary Vaccine Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030
    Table 46. Global Veterinary Vaccine Sales Volume by Region (2019-2024) & (M Doses)
    Table 47. Global Veterinary Vaccine Sales Volume by Region (2025-2030) & (M Doses)
    Table 48. Global Veterinary Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Veterinary Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Veterinary Vaccine Average Price by Region (2019-2024) & (USD/K Doses)
    Table 51. Global Veterinary Vaccine Average Price by Region (2025-2030) & (USD/K Doses)
    Table 52. Key Countries/Regions Veterinary Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Veterinary Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Veterinary Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Veterinary Vaccine Sales Volume, (2019-2024) & (M Doses)
    Table 56. Key Countries/Regions Veterinary Vaccine Sales Volume, (2025-2030) & (M Doses)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 60. Merck Veterinary Vaccine Product Offerings
    Table 61. Merck Recent Development
    Table 62. Zoetis Company Information
    Table 63. Zoetis Introduction and Business Overview
    Table 64. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 65. Zoetis Veterinary Vaccine Product Offerings
    Table 66. Zoetis Recent Development
    Table 67. Boehringer Ingelheim Company Information
    Table 68. Boehringer Ingelheim Introduction and Business Overview
    Table 69. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 70. Boehringer Ingelheim Veterinary Vaccine Product Offerings
    Table 71. Boehringer Ingelheim Recent Development
    Table 72. Ceva Company Information
    Table 73. Ceva Introduction and Business Overview
    Table 74. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 75. Ceva Veterinary Vaccine Product Offerings
    Table 76. Ceva Recent Development
    Table 77. CAHIC Company Information
    Table 78. CAHIC Introduction and Business Overview
    Table 79. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 80. CAHIC Veterinary Vaccine Product Offerings
    Table 81. CAHIC Recent Development
    Table 82. HVRI Company Information
    Table 83. HVRI Introduction and Business Overview
    Table 84. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 85. HVRI Veterinary Vaccine Product Offerings
    Table 86. HVRI Recent Development
    Table 87. Ringpu Biology Company Information
    Table 88. Ringpu Biology Introduction and Business Overview
    Table 89. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 90. Ringpu Biology Veterinary Vaccine Product Offerings
    Table 91. Ringpu Biology Recent Development
    Table 92. Yebio Company Information
    Table 93. Yebio Introduction and Business Overview
    Table 94. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 95. Yebio Veterinary Vaccine Product Offerings
    Table 96. Yebio Recent Development
    Table 97. DHN Company Information
    Table 98. DHN Introduction and Business Overview
    Table 99. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 100. DHN Veterinary Vaccine Product Offerings
    Table 101. DHN Recent Development
    Table 102. WINSUN Company Information
    Table 103. WINSUN Introduction and Business Overview
    Table 104. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 105. WINSUN Veterinary Vaccine Product Offerings
    Table 106. WINSUN Recent Development
    Table 107. Elanco Company Information
    Table 108. Elanco Introduction and Business Overview
    Table 109. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 110. Elanco Veterinary Vaccine Product Offerings
    Table 111. Elanco Recent Development
    Table 112. Virbac Company Information
    Table 113. Virbac Introduction and Business Overview
    Table 114. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 115. Virbac Veterinary Vaccine Product Offerings
    Table 116. Virbac Recent Development
    Table 117. Jinyu Bio-Technology Company Information
    Table 118. Jinyu Bio-Technology Introduction and Business Overview
    Table 119. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 120. Jinyu Bio-Technology Veterinary Vaccine Product Offerings
    Table 121. Jinyu Bio-Technology Recent Development
    Table 122. ChengDu Tecbond Company Information
    Table 123. ChengDu Tecbond Introduction and Business Overview
    Table 124. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 125. ChengDu Tecbond Veterinary Vaccine Product Offerings
    Table 126. ChengDu Tecbond Recent Development
    Table 127. CAVAC Company Information
    Table 128. CAVAC Introduction and Business Overview
    Table 129. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 130. CAVAC Veterinary Vaccine Product Offerings
    Table 131. CAVAC Recent Development
    Table 132. Kyoto Biken Laboratories Company Information
    Table 133. Kyoto Biken Laboratories Introduction and Business Overview
    Table 134. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 135. Kyoto Biken Laboratories Veterinary Vaccine Product Offerings
    Table 136. Kyoto Biken Laboratories Recent Development
    Table 137. FATRO Company Information
    Table 138. FATRO Introduction and Business Overview
    Table 139. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 140. FATRO Veterinary Vaccine Product Offerings
    Table 141. FATRO Recent Development
    Table 142. Vaksindo Company Information
    Table 143. Vaksindo Introduction and Business Overview
    Table 144. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 145. Vaksindo Veterinary Vaccine Product Offerings
    Table 146. Vaksindo Recent Development
    Table 147. Bio-Labs Company Information
    Table 148. Bio-Labs Introduction and Business Overview
    Table 149. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 150. Bio-Labs Veterinary Vaccine Product Offerings
    Table 151. Bio-Labs Recent Development
    Table 152. Avimex Animal Health Company Information
    Table 153. Avimex Animal Health Introduction and Business Overview
    Table 154. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 155. Avimex Animal Health Veterinary Vaccine Product Offerings
    Table 156. Avimex Animal Health Recent Development
    Table 157. MEVAC Company Information
    Table 158. MEVAC Introduction and Business Overview
    Table 159. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 160. MEVAC Veterinary Vaccine Product Offerings
    Table 161. MEVAC Recent Development
    Table 162. Biovac Company Information
    Table 163. Biovac Introduction and Business Overview
    Table 164. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 165. Biovac Veterinary Vaccine Product Offerings
    Table 166. Biovac Recent Development
    Table 167. Atafen Company Information
    Table 168. Atafen Introduction and Business Overview
    Table 169. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 170. Atafen Veterinary Vaccine Product Offerings
    Table 171. Atafen Recent Development
    Table 172. Dyntec Company Information
    Table 173. Dyntec Introduction and Business Overview
    Table 174. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 175. Dyntec Veterinary Vaccine Product Offerings
    Table 176. Dyntec Recent Development
    Table 177. RVSRI Introduction and Business Overview
    Table 178. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 179. RVSRI Veterinary Vaccine Product Offerings
    Table 180. RVSRI Recent Development
    Table 181. RVSRI Company Information
    Table 182. Medion Company Information
    Table 183. Medion Introduction and Business Overview
    Table 184. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
    Table 185. Medion Veterinary Vaccine Product Offerings
    Table 186. Medion Recent Development
    Table 187. Key Raw Materials Lists
    Table 188. Raw Materials Key Suppliers Lists
    Table 189. Veterinary Vaccine Downstream Customers
    Table 190. Veterinary Vaccine Distributors List
    Table 191. Research Programs/Design for This Report
    Table 192. Key Data Information from Secondary Sources
    Table 193. Key Data Information from Primary Sources
List of Figures
    Figure 1. Veterinary Vaccine Product Picture
    Figure 2. Global Veterinary Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Veterinary Vaccine Sales Volume (2019-2030) & (M Doses)
    Figure 5. Global Veterinary Vaccine Sales Price (2019-2030) & (USD/K Doses)
    Figure 6. Veterinary Vaccine Report Years Considered
    Figure 7. Global Veterinary Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Veterinary Vaccine Players Sales Volume Ranking (2023) & (M Doses)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Vaccine Revenue in 2023
    Figure 10. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Live Attenuated Vaccines Picture
    Figure 12. Inactivated Vaccines Picture
    Figure 13. Other Picture
    Figure 14. Global Veterinary Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Veterinary Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Veterinary Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
    Figure 17. Global Veterinary Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Veterinary Vaccine Price by Type (2019-2030) & (USD/K Doses)
    Figure 19. Product Picture of Farm Animal
    Figure 20. Product Picture of Companion Animal
    Figure 21. Global Veterinary Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Veterinary Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Veterinary Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
    Figure 24. Global Veterinary Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Veterinary Vaccine Price by Application (2019-2030) & (USD/K Doses)
    Figure 26. North America Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Veterinary Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Veterinary Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Veterinary Vaccine Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Veterinary Vaccine Sales Volume (%), (2019-2030)
    Figure 38. United States Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Veterinary Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Veterinary Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Veterinary Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 59. Veterinary Vaccine Industrial Chain
    Figure 60. Veterinary Vaccine Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure